Intercept Pharmaceuticals | Passifs Courants



Current Liabilities Changement Date
Acadia Pharmaceuticals USD 302.53M 92.34M 2025-03
Alnylam Pharmaceuticals USD 1.08B 110.65M 2025-03
Amarin USD 162.41M 17.54M 2025-03
Amgen USD 23.01B 91M 2025-03
Arrowhead Research USD 220.54M 126.78M 2025-03
AstraZeneca USD 29.13B 1.26B 2025-03
Biogen USD 5.3B 231.4M 2025-03
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Eli Lilly USD 30.07B 1.69B 2025-03
Gilead Sciences USD 12B 279M 2024-12
GlaxoSmithKline GBP 20.83B 866M 2025-03
Incyte USD 1.89B 244.96M 2025-03
Ionis Pharmaceuticals USD 250.29M 59.02M 2025-03
Moderna USD 1.6B 602M 2025-03
Neurocrine Biosciences USD 507.7M 78M 2024-12
Novartis USD 28.69B 560M 2024-12
PTC Therapeutics USD 595.39M 14.41M 2025-03
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Sarepta Therapeutics USD 605.59M 126.1M 2025-03
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12



Intercept Pharmaceuticals Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.